fibrosing colonopathy

fibrosing colonopathy

colonic fibrosis seen in cystic fibrosis patients, thought to be due to pancreatins.

fi·bros·ing co·lon·op·a·thy

(fī-brōs'ing kō'lŏn-op'ă-thē)
Colonic fibrosis seen in cystic fibrosis patients, thought to be due to pancreatins.
References in periodicals archive ?
Important Safety Information CREON may increase the chance of having a rare bowel disorder called fibrosing colonopathy.
Solvay will also be required to conduct a 10-year observational study to evaluate the incidence of fibrosing colonopathy in cystic fibrosis patients treated with Creon, and to evaluate the risk of transmission of selected porcine viruses in treated patients, according to the FDA approval letter.
Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
High dose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
This case suggests that multiple etiologic factors, and not simply exposure to pancreatic enzymes, may result in fibrosing colonopathy in adults with cystic fibrosis.
Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
The incidence of fibrosing colonopathy, associated with high doses of pancreatic enzymes and/or the use of high strength preparations in the early 1990s (7-9), caused many centres treating CF to review the practices of their patients and collaborate to produce national guidelines (4,10,11).
Individuals with CF and their parents were advised against self-adjusting the dose in the 1990s when fibrosing colonopathy was identified by other centres.
PANCREAZE may increase your chance of having a serious, rare bowel disorder called fibrosing colonopathy that may require surgery.
As part of the REMS, a Medication Guide with important dosing and safety information applicable to this class of products, including CREON(R), is provided for patients and caregivers, with an emphasis on understanding the risk of fibrosing colonopathy as well as the importance of not over- or under-dosing.
As part of the REMS, a Medication Guide with important dosing and safety information applicable to this class of products, including CREON, is provided for patients and caregivers, with an emphasis on understanding the risk of fibrosing colonopathy as well as the importance of not over- or under-dosing.